Inify Laboratories – mandatory notification of trade
Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun […]
Successful launch of Inify Laboratories’ services, with first patient cases diagnosed
“The beginning of a paradigm shift within pathology” STOCKHOLM – June 20, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, announces the opening of […]
Inify Laboratories AB (publ) – summary of Annual General Meeting
Inify Laboratories, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 16, 2023. A total of 34,075,774 shares were represented at the Annual General Meeting, corresponding to 75.3% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main decisions made, for further details please refer to the notice available on the company's website.
Inify Laboratories – Strong market interest and launch on track
STOCKHOLM – April 26th, 2023 – Inify Laboratories, a fully integrated digital ultramodern laboratory service that provides cancer diagnostics within pathology, is on track for launch at the end of […]
Inify Laboratories – Annual Report 2022
Stockholm – April 12, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, […]
Inify Laboratories – notice of Annual General Meeting on May 16, 2023
Stockholm – April 12, 2023 – Inify Laboratories AB (publ), a company providing fully digitalized laboratory services within prostate cancer diagnostics, hereby invites its shareholders to Annual General Meeting on […]
Panel talk about Inify’s fourth quarter 2022
During the last quarter of 2022, Inify Laboratories moved into its brand-new premises at Campus Solna just outside of Stockholm. The laboratory was finished in record time and all essential […]
Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time
STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has completed its new laboratory – including staffing up with skilled […]
Panel talk about Inify’s third quarter
The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping […]
Inify Laboratories – Laboratory and recruitment on track with positive market feedback
STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated […]